AMAM
Ambrx Biopharma Inc
AMAM
AMAM
Delisted
AMAM was delisted on the 6th of March, 2024.
68 hedge funds and large institutions have $913M invested in Ambrx Biopharma Inc in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
46% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 13
26% more call options, than puts
Call options by funds: $4.72M | Put options by funds: $3.74M
Holders
68
Holding in Top 10
6
Calls
$4.72M
Puts
$3.74M
Top Buyers
| 1 | +$52.8M | |
| 2 | +$44.6M | |
| 3 | +$30.7M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$28.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19.9M |
Top Sellers
| 1 | -$40.5M | |
| 2 | -$29.4M | |
| 3 | -$5.6M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$5.02M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.08M |
